Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

COVID-19 and neurological disorders: are neurodegenerative or neuroimmunological diseases more vulnerable?
Luigi Ferini‐Strambi, Maria Salsone
Journal of Neurology (2020) Vol. 268, Iss. 2, pp. 409-419
Open Access | Times Cited: 147

Showing 1-25 of 147 citing articles:

Pathological sequelae of long-haul COVID
Saurabh Mehandru, Miriam Mérad
Nature Immunology (2022) Vol. 23, Iss. 2, pp. 194-202
Open Access | Times Cited: 586
Unraveling the Mystery Surrounding Post-Acute Sequelae of COVID-19
Rakhee K. Ramakrishnan, Tarek Kashour, Qutayba Hamid, et al.
Frontiers in Immunology (2021) Vol. 12
Open Access | Times Cited: 217
COVID-19-Associated Neurological Disorders: The Potential Route of CNS Invasion and Blood-Brain Barrier Relevance
Aneesha Achar, Chaitali Ghosh
Cells (2020) Vol. 9, Iss. 11, pp. 2360-2360
Open Access | Times Cited: 147
Economics of Artificial Intelligence in Healthcare: Diagnosis vs. Treatment
Narendra N. Khanna, Mahesh Maindarkar, Vijay Viswanathan, et al.
Healthcare (2022) Vol. 10, Iss. 12, pp. 2493-2493
Open Access | Times Cited: 145
SARS-CoV-2 drives NLRP3 inflammasome activation in human microglia through spike protein
Eduardo A. Albornoz, Alberto A. Amarilla, Naphak Modhiran, et al.
Molecular Psychiatry (2022) Vol. 28, Iss. 7, pp. 2878-2893
Open Access | Times Cited: 126
Phytochemicals as Anti-Inflammatory Agents in Animal Models of Prevalent Inflammatory Diseases
Seong A. Shin, Byeong Jun Joo, Jun Seob Lee, et al.
Molecules (2020) Vol. 25, Iss. 24, pp. 5932-5932
Open Access | Times Cited: 109
The prognostic value of comorbidity for the severity of COVID-19: A systematic review and meta-analysis study
Mobina Fathi, Kimia Vakili, Fatemeh Sayehmiri, et al.
PLoS ONE (2021) Vol. 16, Iss. 2, pp. e0246190-e0246190
Open Access | Times Cited: 98
Blood Biomarkers for Detection of Brain Injury in COVID-19 Patients
Steven T. DeKosky, Patrick M. Kochanek, Alex B. Valadka, et al.
Journal of Neurotrauma (2020) Vol. 38, Iss. 1, pp. 1-43
Open Access | Times Cited: 77
The impact of COVID-19 and social distancing on people with Parkinson’s disease: a survey study
Megan Feeney, Yaqian Xu, Matthew Surface, et al.
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 72
Heterogeneity in Regional Damage Detected by Neuroimaging and Neuropathological Studies in Older Adults With COVID-19: A Cognitive-Neuroscience Systematic Review to Inform the Long-Term Impact of the Virus on Neurocognitive Trajectories
Riccardo Manca, Matteo De Marco, Paul G. Ince, et al.
Frontiers in Aging Neuroscience (2021) Vol. 13
Open Access | Times Cited: 71
How COVID-19 will boost remote exercise-based treatment in Parkinson’s disease: a narrative review
A. Langer, Lucia Gassner, Anna Flotz, et al.
npj Parkinson s Disease (2021) Vol. 7, Iss. 1
Open Access | Times Cited: 67
Emerging COVID-19 Neurological Manifestations: Present Outlook and Potential Neurological Challenges in COVID-19 Pandemic
Saikat Dewanjee, V. Jayalakshmi, Rajkumar Singh Kalra, et al.
Molecular Neurobiology (2021) Vol. 58, Iss. 9, pp. 4694-4715
Open Access | Times Cited: 64
Predictors of infection, symptoms development, and mortality in people with SARS-CoV-2 living in retirement nursing homes
Andrea De Vito, Vito Fiore, Elija Princic, et al.
PLoS ONE (2021) Vol. 16, Iss. 3, pp. e0248009-e0248009
Open Access | Times Cited: 63
Alzheimer’s and Parkinson’s Diseases Predict Different COVID-19 Outcomes: A UK Biobank Study
Yizhou Yu, Marco Travaglio, Rebeka Popovic, et al.
Geriatrics (2021) Vol. 6, Iss. 1, pp. 10-10
Open Access | Times Cited: 57
Bridging Knowledge Gaps in the Diagnosis and Management of Neuropsychiatric Sequelae of COVID-19
Jennifer Frontera, Naomi M. Simon
JAMA Psychiatry (2022) Vol. 79, Iss. 8, pp. 811-811
Open Access | Times Cited: 50
Neurological complications associated with Covid‐19; molecular mechanisms and therapeutic approaches
Mohammad Mahboubi Mehrabani, Mohammad Sobhan Karvandi, Pedram Maafi, et al.
Reviews in Medical Virology (2022) Vol. 32, Iss. 6
Open Access | Times Cited: 47
COVID-19 causes neuronal degeneration and reduces neurogenesis in human hippocampus
Amir‐Hossein Bayat, Helia Azimi, Meysam Hassani Moghaddam, et al.
APOPTOSIS (2022) Vol. 27, Iss. 11-12, pp. 852-868
Open Access | Times Cited: 46
Exploring the Paradox of COVID-19 in Neurological Complications with Emphasis on Parkinson’s and Alzheimer’s Disease
Sachchida Nand, Neeraj Tiwari, Payal Singh, et al.
Oxidative Medicine and Cellular Longevity (2022) Vol. 2022, pp. 1-16
Open Access | Times Cited: 43
The Effects of SARS-CoV-2 Infection on the Cognitive Functioning of Patients with Pre-Existing Dementia
Souvik Dubey, Shambaditya Das, Ritwik Ghosh, et al.
Journal of Alzheimer s Disease Reports (2023) Vol. 7, Iss. 1, pp. 119-128
Open Access | Times Cited: 36
Phenolic Compounds of Therapeutic Interest in Neuroprotection
José Manuel Nájera-Maldonado, Ricardo Salazar, Patricia Álvarez-Fitz, et al.
Journal of Xenobiotics (2024) Vol. 14, Iss. 1, pp. 227-246
Open Access | Times Cited: 12
Potential convergence of olfactory dysfunction in Parkinson’s disease and COVID-19: The role of neuroinflammation
Hui Li, Junliang Qian, Youcui Wang, et al.
Ageing Research Reviews (2024) Vol. 97, pp. 102288-102288
Closed Access | Times Cited: 7
Risk of Hospitalization and Death for COVID ‐19 in People with Parkinson's Disease or Parkinsonism
Luca Vignatelli, Corrado Zenesini, Laura Maria Beatrice Belotti, et al.
Movement Disorders (2020) Vol. 36, Iss. 1, pp. 1-10
Open Access | Times Cited: 54
Review: How Can Intelligent Robots and Smart Mechatronic Modules Facilitate Remote Assessment, Assistance, and Rehabilitation for Isolated Adults With Neuro-Musculoskeletal Conditions?
S. Farokh Atashzar, Jay Carriere, Mahdi Tavakoli
Frontiers in Robotics and AI (2021) Vol. 8
Open Access | Times Cited: 53
SARS-CoV-2 Exacerbates Beta-Amyloid Neurotoxicity, Inflammation and Oxidative Stress in Alzheimer’s Disease Patients
Luigi Chiricosta, Agnese Gugliandolo, Emanuela Mazzon
International Journal of Molecular Sciences (2021) Vol. 22, Iss. 24, pp. 13603-13603
Open Access | Times Cited: 40
Emerging Roles of Type-I Interferons in Neuroinflammation, Neurological Diseases, and Long-Haul COVID
Ping-Heng Tan, Jasmine Ji, Chung‐Hsi Hsing, et al.
International Journal of Molecular Sciences (2022) Vol. 23, Iss. 22, pp. 14394-14394
Open Access | Times Cited: 33
Page 1 - Next Page

Scroll to top